France· FR:63329030
FIRMAGON 80 mg, poudre et solvant pour solution injectable
A medicinal product containing dégarélix (acétate de), registered in France by FERRING PHARMACEUTICALS (DANEMARK), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DÉGARÉLIX (ACÉTATE DE)
- Manufacturer
- FERRING PHARMACEUTICALS (DANEMARK)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009394326871 flacon en verre + 1 seringue préremplie en verre de 4,2 ml + 1 tige de piston + 1 adaptateur-flacon + 1 aiguilleEUR 87.19
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dégarélix (acétate de) in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandDegarelix Accord 80 mg powder and solvent for solution for injectionAccord Healthcare S.L.U.
- NetherlandsDegarelix Accord 80 mg poeder en oplosmiddel voor oplossing voor injectieAccord Healthcare S.L.U.
- United KingdomDegarelix 120mg powder and solvent for solution for injection vialsFerring Pharmaceuticals Ltd
- FinlandDegarelix AccordAccord Healthcare S.L.U.
- CzechiaDEGARELIX ACCORDAccord Healthcare S.L.U., Barcelona
- SwedenDegarelix Accord 120 mg Pulver och vätska till injektionsvätska, lösningAccord Healthcare S.L.U.
- IcelandDegarelix AccordAccord Healthcare S.L.U.
- PolandDegarelix AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Degarelix Accord, Firmagon
- Liechtenstein · Degarelix Accord, Firmagon
- Norway · Degarelix Accord, Firmagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be86496b-4381-446b-98b0-064fbe9396be GET /v1/drugs/be86496b-4381-446b-98b0-064fbe9396be?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63329030",
"date_amm": "2009-02-17",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/08/504",
"substance": "DÉGARÉLIX (ACÉTATE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about dégarélix (acétate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.